Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic
Medicine
[키워드] anti-rheumatic drug
beta-coronavirus
cardiovascular complications
characterized
China
Cluster
connective tissue disease
Course
COVID-19
COVID-19 in patient
COVID-19 infection
Critical
disease
dry cough
elicited
fatigue
Fever
hematological
higher risk
Hydroxychloroquine
hyperinflammation
IL-6
Infection
Inflammatory arthritis
intrinsic
Kawasaki disease
Kawasaki syndrome
majority
Month
Musculoskeletal
myalgia
neurological
outcome
Patient
patients
Respiratory failure
review
rheumatic and musculoskeletal disease
rheumatoid arthritis
SARS-CoV-2
SARS-COV-2 infection
Sepsis
severe pneumonia
SLE
subsequent
syndrome
systemic inflammatory disease
systemic lupus erythematosus
Vasculitis
[DOI] 10.3389/fmed.2020.562142 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2020.562142 PMC 바로가기 [Article Type] Medicine